Inventor · disambiguated record
Thomas Ichim
Also filed as: ICHIM THOMAS · ICHIM THOMAS E · ICHIM THOMAS EMANUEL
56 granted patents·299 pending applications·135 citations·filing 2003–2025
98Inventor score
Files withCREATIVE MEDICAL TECH INC65FIGENE LLC57THERAPEUTIC SOLUTIONS INT INC52BATU BIOLOGICS INC32REGEN BIOPHARMA INC22
Top patents by PatentIndex Score
355 records- 0196US11918605B1Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·6 cites·30 claims
- 0296US11517589B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Dec 6, 2022·9 cites·23 claims
- 0395US11918604B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·3 cites·25 claims
- 0495US11266707B2Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19ICHIM THOMAS E·Filed 2020·Granted Mar 8, 2022·8 cites·16 claims
- 0593US11229674B1Nutraceuticals for suppressing indolamine 2,3 deoxygenaseICHIM THOMAS E·Filed 2020·Granted Jan 25, 2022·7 cites·19 claims
- 0692US9364601B2Extracorporeal removal of microvesicular particlesAETHLON MEDICAL INC·Filed 2012·Granted Jun 14, 2016·16 cites·17 claims
- 0790US11504410B2Neuroprotection and neuroregeneration by pterostilbene and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Nov 22, 2022·2 cites·19 claims
- 0890US11034934B2Methods of enhancing fibroblast therapeutic activitySPINALCYTE LLC·Filed 2018·Granted Jun 15, 2021·7 cites·13 claims
- 0990US8372797B2Treatment of erectile dysfunction by stem cell therapyCREATIVE MEDICAL HEALTH INC·Filed 2007·Granted Feb 12, 2013·20 cites·10 claims
- 1088US9598673B2Treatment of disc degenerative diseaseICHIM THOMAS E·Filed 2007·Granted Mar 21, 2017·6 cites·4 claims
- 1188US8288172B2Extracorporeal removal of microvesicular particlesICHIM THOMAS·Filed 2007·Granted Oct 16, 2012·15 cites·11 claims
- 1287US8241621B2Stem cell mediated treg activation/expansion for therapeutic immune modulationICHIM THOMAS E·Filed 2007·Granted Aug 14, 2012·7 cites·8 claims
- 1387US2024207309A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1486US10383895B2Stimulation of therapeutic angiogenesis by T regulatory cellsVIERA BIOSCIENCE INC·Filed 2017·Granted Aug 20, 2019·3 cites·8 claims
- 1585US2024034797A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2023·Application pending·0 cites
- 1684US12090174B2Fibroblast therapy for treatment of Duchenne muscular dystrophySPINALCYTE LLC·Filed 2020·Granted Sep 17, 2024·1 cites·23 claims
- 1784US11141471B2Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cellsREGEN BIOPHARMA INC·Filed 2017·Granted Oct 12, 2021·3 cites·13 claims
- 1884US9707333B2Extracorporeal removal of microvesicular particlesAETHLON MEDICAL INC·Filed 2014·Granted Jul 18, 2017·5 cites·14 claims
- 1982US12133870B2Treatment of opioid addiction using fibroblasts and products thereofSPINALCYTE LLC·Filed 2020·Granted Nov 5, 2024·1 cites·31 claims
- 2082US11975030B2Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereofFIGENE LLC·Filed 2020·Granted May 7, 2024·1 cites·7 claims
- 2182US11090332B2Antigen specific mRNA cellular cancer vaccinesREGEN BIOPHARMA INC·Filed 2016·Granted Aug 17, 2021·2 cites·13 claims
- 2281US11878037B2Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosisFIGENE LLC·Filed 2020·Granted Jan 23, 2024·1 cites·31 claims
- 2381US11759495B2Upregulation of therapeutic T regulatory cells and suppression of suicidal ideations in response to inflammation by administration of nutraceutical compositions alone or combined with minocyclineTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Sep 19, 2023·1 cites·19 claims
- 2481US2024293469A1Fibroblast delivery of tumor inhibitory agentsFIGENE LLC·Filed 2024·Application pending·0 cites
- 2581US2024293468A1Fibroblast delivery of tumor inhibitory agentsFIGENE LLC·Filed 2024·Application pending·0 cites
- 2680US11959102B2Augmentation of fibroblast regenerative activityFIGENE LLC·Filed 2018·Granted Apr 16, 2024·1 cites·17 claims
- 2780US2022175831A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2880US2022175830A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2980US2022202856A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3079US10842815B2Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapiesCREATIVE MEDICAL TECH INC·Filed 2018·Granted Nov 24, 2020·1 cites·20 claims
- 3179US2025041352A1Treatment of opioid addiction using fibroblasts and products thereofSPINALCYTE LLC·Filed 2024·Application pending·0 cites
- 3279US2022118010A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3378US12310991B2Stimulation of angiogenesis by fibroblast derived exosomesSPINALCYTE LLC·Filed 2018·Granted May 27, 2025·1 cites·32 claims
- 3477US10660891B2Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereofHARROW IP LLC·Filed 2019·Granted May 26, 2020·1 cites·27 claims
- 3577US9427450B2Therapeutic immune modulation by stem cell secreted exosomesMEDISTEM INC·Filed 2013·Granted Aug 30, 2016·3 cites·18 claims
- 3677US2024287459A1Means and methods of preventing or reversing agingFIGENE LLC·Filed 2024·Application pending·0 cites
- 3777US2025115867A1Augmentation of cell therapy efficacy including treatment with alpha, 1,3 fucosyltransferaseTARGAZYME INC·Filed 2024·Application pending·0 cites
- 3876US11241427B2Small molecule modulators of NR2F6 activityREGEN BIOPHARMA INC·Filed 2016·Granted Feb 8, 2022·1 cites·9 claims
- 3976US11053503B2Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibitionREGEN BIOPHARMA INC·Filed 2017·Granted Jul 6, 2021·1 cites·8 claims
- 4076US2025041351A1Fibroblast therapy for treatment of duchenne muscular dystrophySPINALCYTE LLC·Filed 2024·Application pending·0 cites
- 4176US2024263140A1Augmentation of fibroblast regenerative activityFIGENE LLC·Filed 2024·Application pending·0 cites
- 4276US2021252053A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4376US2022249363A1Augmentation of personalized tumor specific adaptive immunity through extracorporeal removal of immune blocking factorsIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 4475US11814430B2Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Granted Nov 14, 2023·0 cites·11 claims
- 4575US10869916B2Therapeutic immune modulation by stem cell secreted exosomesXON CELLS INC·Filed 2018·Granted Dec 22, 2020·1 cites·15 claims
- 4675US2024271093A1Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferaseTARGAZYME INC·Filed 2024·Application pending·0 cites
- 4774US2022041730A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 4874US2022041729A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 4974US2024261336A1Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereofFIGENE LLC·Filed 2024·Application pending·0 cites
- 5074US2024269193A1Stimulation of angiogenesis by fibroblast derived exosomesFIGENE LLC·Filed 2024·Application pending·0 cites
Showing the top 50 of 355 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Ichim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →